Skip to content

September 21, 2026 • Dr. Alex Movshis

Botox Injection Sites for Migraines: The 31-Site PREEMPT Map, Why It Is 155 Units, and Where Each Injection Goes

Botox Injection Sites for Migraines: The 31-Site PREEMPT Map, Why It Is 155 Units, and Where Each Injection Goes

The first question at almost every Botox™ consultation for migraine is not whether it works. It is where the needles go and how many there are. The answer is more specific than most patients expect: 31 injections, 155 units, seven muscle areas, the same map for everyone, repeated every 12 weeks. It is one of the few treatments in headache medicine where the protocol was fixed by two large trials and then written into the FDA label unchanged, which means the map you receive should be the map the evidence was built on.

This post lays out that map site by site, explains why each area is in it, and covers the one thing that varies between patients, the injector’s technique. It also explains why the extra follow-the-pain units from the trials are not added here.

Why the map is fixed, and where it came from

Earlier botulinum toxin trials in headache used different doses and injection maps and gave mixed results. The approach evolved from a set of fixed sites alone to fixed sites plus follow-the-pain sites, and PREEMPT standardized that combination (Blumenfeld 2010): sites and doses chosen to cover the sensory nerve territories of the head and neck, given identically to every patient, in two placebo-controlled trials totaling 1,384 adults with chronic migraine. Headache days fell by 8.4 a month with Botox™ against 6.6 with placebo at 24 weeks (Dodick 2010), they kept falling through the 56-week open-label extension (Aurora 2011), and the FDA approved the 155-unit map in 2010. When a physician quotes “155 units at 31 sites,” that is the map.

The anatomical logic was spelled out afterward by the same investigators (Blumenfeld 2017). Migraine pain arrives through two systems that meet in the brainstem: the trigeminal nerve, whose supraorbital, supratrochlear, and auriculotemporal branches supply the forehead, brow, and temple, and the upper cervical nerves, whose greater and lesser occipital branches supply the back of the head and the neck. Botox™ quiets the sensory nerve endings it is injected near, blocking the release of the neuropeptides that keep the whole network sensitized (Burstein 2020). Each of the seven muscle areas in the map sits over one of those nerve territories. The muscles are the address, not the target.

Watch: Botox for Chronic Migraine: Not the Muscles, the Nerve Endings Narrated animation · 1:14 · Educational only, not medical advice.
Read the film's transcript

Everyone assumes Botox for migraine relaxes muscles. It doesn't. Chronic migraine, headache more days than not, is a nerve disease.

A web of sensory nerves wraps your scalp and the lining around your brain. Their tiny endings are the alarm wires.

In an attack those endings release signaling chemicals, CGRP among them, inflaming the lining, sensitizing the system. That pain is real.

Botox slips into those endings and cuts the docking protein, SNAP-25, so the packets can't release. Fewer alarms reach the brain.

So it's a map of small injections across the forehead, the temples, the back of the head and the neck, following the nerves, plus a few where it hurts.

Usually, it's a sore neck or a heavy eyelid for a few weeks. Rarely, trouble swallowing, breathing, or weakness that spreads. These need the nearest emergency room, or call 911.

This is prevention, not rescue. It's approved for chronic migraine, the goal is fewer headache days, and it builds over repeated cycles. Educational only. See a specialist.

The 31 sites, area by area

Every injection is 5 units in 0.1 mL of saline, given with a 30-gauge half-inch needle into the superficial part of the muscle, and the map is symmetrical, so each area is injected on both sides (Blumenfeld 2010).

Corrugator — 10 units, 2 sites. One injection into each corrugator, the small muscle that pulls the brow inward when you frown, placed at the upper margin of the brow above the inner third of the eyebrow. This covers the supratrochlear nerve. The needle is directed upward and away from the orbit, because the eyelid-lifting muscle sits just below.

Procerus — 5 units, 1 site. A single midline injection at the bridge of the nose, into the muscle that pulls the brows down. The only site that is not paired.

Frontalis — 20 units, 4 sites. Two injections into each side of the forehead muscle, in the upper half of the forehead, roughly above the corrugator site and above the mid-pupil line. These cover the supraorbital nerve. Placing them high keeps the effect off the brow and the eyelid.

Temporalis — 40 units, 8 sites. Four injections fanned across each temporalis, the broad muscle above and behind the ear that you feel bulge when you clench your jaw. This is the largest dose in the map, and it covers the temple, where the auriculotemporal nerve and its branches run. The sites run from just above the ear toward the hairline.

Occipitalis — 30 units, 6 sites. Three injections into each occipitalis, along the ridge at the base of the skull, covering the greater and lesser occipital nerves as they emerge. This is the back-of-the-head territory, and a course that skips it leaves that territory untreated.

Cervical paraspinal — 20 units, 4 sites. Two injections into each side of the upper neck muscles, just below the skull, deliberately high and superficial. Neck pain is the most common side effect of the protocol (Diener 2014), and depth is a variable that affects it, so the needle stays shallow (Blumenfeld 2017).

Trapezius — 30 units, 6 sites. Three injections into each upper trapezius, spaced from the base of the neck toward the point of the shoulder, covering the cervical branches that feed the neck-and-shoulder component of the headache. The sites are adjusted to the patient’s build, and a slender patient gets them closer to the neck.

Ten, five, twenty, forty, thirty, twenty, thirty: 155 units. Two, one, four, eight, six, four, six: 31 sites.

Wondering whether you qualify for the protocol? The chronic migraine Botox eligibility check takes two minutes. Or book a consultation with Dr. Movshis — same-week appointments, prior authorization submitted at the first visit. Call (646) 290-6660.

Follow the pain: the 40 units the trials allowed, and why they are not added here

The 31 fixed sites are given to everyone. On top of them, the PREEMPT trial design allowed up to 40 additional units at up to 8 extra sites, placed where the individual patient’s pain concentrates: up to 10 units more in the temporalis, up to 10 more in the occipitalis, and up to 20 more in the trapezius, on one side or both. That takes the maximum to 195 units at 39 sites, and the trial patients received 155 to 195 units, so the results cover both the fixed map and the map with additions (Dodick 2010).

In the U.S. the label carries the 155-unit map, and Modal Pain Management NYC gives exactly that at every session, with no add-on units. When the response is real but a specific area — one temple, the back of the head, a shoulder — keeps breaking through, the answer is to keep the full protocol going for two or three rounds and to look for a second diagnosis, such as occipital neuralgia or a headache from the neck, that the map is not designed for.

Why fewer sites, or the wrong sites, fails

Three things can go wrong with courses that did not work elsewhere, and the anatomy paper addresses each (Blumenfeld 2017). The first is an incomplete map: forehead and temples only, which covers the trigeminal half of the network and leaves the occipital half untouched. The second is depth, mostly in the neck, where injections placed into the deeper postural muscles produce weakness and a heavy head without adding benefit. The third is timing: judging the treatment after one cycle. In the 56-week analysis the reduction in headache days kept growing through the second and third cycles (Aurora 2011), which is why the decision to continue or stop is made after cycle two or three, and why a first course with fewer than 31 sites is not a fair test of whether Botox™ works for you.

Units are the other source of confusion. Botox™ units are specific to onabotulinumtoxinA. Dysport™ and Xeomin™ units are not equivalent, no conversion factor is reliable, and neither product is FDA-approved for chronic migraine. A patient who was told they received “100 units” or “300 units” of another product for headache was not given the PREEMPT protocol.

What the session is like

The 31 injections take about ten minutes once the map is drawn. The needle is short and fine, each injection is a brief sting, and the forehead and temple sites are the ones patients feel most. There is no sedation and no downtime. Small bumps at the forehead sites settle within an hour. Patients drive themselves and return to work, and are asked not to rub or massage the injected areas that day, a precaution rather than a proven rule. Some people notice fewer headache days within the first month, and others only in the second or third round, so the response is judged after two or three rounds. Each round is repeated at 12 weeks. The side effects, and the technique that prevents most of them, are covered in the side-effects guide.

The map is reproduced exactly at Modal Pain Management NYC, with the adjustments the anatomy work supports: brow sites high and angled away from the orbit, paraspinal sites shallow, trapezius sites fitted to the patient’s build, and the dose held at 155 units. Prior authorization for commercially insured patients is submitted at the first visit, and the coverage guide explains what it needs. The full treatment guide covers everything from the first visit to results, and the 74-second animation shows what the toxin does at the nerve ending.

References

  1. Blumenfeld A, Silberstein SD, Dodick DW, Aurora SK, Turkel CC, Binder WJ. Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program. Headache. 2010;50(9):1406–1418. doi:10.1111/j.1526-4610.2010.01766.x · PubMed 20958294
  2. Blumenfeld AM, Silberstein SD, Dodick DW, Aurora SK, Brin MF, Binder WJ. Insights into the functional anatomy behind the PREEMPT injection paradigm: guidance on achieving optimal outcomes. Headache. 2017;57(5):766–777. doi:10.1111/head.13074 · PubMed 28387038
  3. Dodick DW, Turkel CC, DeGryse RE, et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. 2010;50(6):921–936. doi:10.1111/j.1526-4610.2010.01678.x · PubMed 20487038
  4. Aurora SK, Winner P, Freeman MC, et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program. Headache. 2011;51(9):1358–1373. doi:10.1111/j.1526-4610.2011.01990.x · PubMed 21883197
  5. Burstein R, Blumenfeld AM, Silberstein SD, Manack Adams A, Brin MF. Mechanism of action of onabotulinumtoxinA in chronic migraine: a narrative review. Headache. 2020;60(7):1259–1272. doi:10.1111/head.13849 · PubMed 32602955
  6. Diener HC, Dodick DW, Turkel CC, et al. Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine. Eur J Neurol. 2014;21(6):851–859. doi:10.1111/ene.12393 · PubMed 24628923

Which question is yours? What it usually means, and what we do about it

The map is fixed by the FDA label. What varies is whether you qualify and what your plan requires.

Headache on 15 or more days a month, at least 8 with migraine features, and you want to know what the session involves

Usually: Chronic migraine, the FDA-approved indication for the 155-unit, 31-site protocol

At Modal Pain: PREEMPT-protocol injections every 12 weeks, prior authorization handled by our office

You have had Botox elsewhere at fewer sites, a lower dose, or only in the forehead and temples, and it did not work

Usually: An incomplete map, one possible reason a first course fails

At Modal Pain: A full 31-site protocol course of at least two rounds before judging the response

The 155 units help but the pain still breaks through in the temples, the back of the head, or one shoulder

Usually: A partial response to the fixed protocol, judged over two or three rounds

At Modal Pain: The same 155-unit, 31-site protocol for at least two or three rounds, since headache days kept falling across rounds in the trials, and a second look for a headache the map is not designed for

Modal Pain Management NYC accepts most commercial PPO plans, including Aetna, Anthem Blue Cross Blue Shield, Cigna, Empire Blue Cross Blue Shield, the Empire Plan, Oscar, Oxford, UMR and UnitedHealthcare, and does not accept Medicare, Medicaid, HMO plans, or workers' compensation. Botox for chronic migraine needs prior authorization, which our office submits after the consultation. Self-pay pricing for the 155-unit protocol is published, with no surprise fees. Insurance details · Self-pay pricing

369 Lexington Ave, Floor 25, New York, NY 10017 · same-week appointments are routinely available · in-suite ultrasound and fluoroscopy.

Frequently Asked Questions

155 units per session, given as 31 injections of 5 units across seven muscle areas: corrugator (10 units, 2 sites), procerus (5 units, 1 site), frontalis (20 units, 4 sites), temporalis (40 units, 8 sites), occipitalis (30 units, 6 sites), cervical paraspinal (20 units, 4 sites), and trapezius (30 units, 6 sites). That is the paradigm tested in the PREEMPT trials and written into the FDA label, repeated every 12 weeks (Blumenfeld 2010). The PREEMPT trial design also allowed up to 40 follow-the-pain units at up to 8 more sites, for a maximum of 195 units. Modal Pain Management NYC gives the fixed 155-unit protocol and does not add them. Botox units are specific to Botox and cannot be converted to Dysport or Xeomin units.

Seven muscle areas on the head and neck, injected on both sides. Between the eyebrows: one site in each corrugator and one in the procerus at the bridge of the nose. Forehead: two sites in each frontalis. Temples: four sites in each temporalis, fanned over the muscle above and behind the ear. Back of the head: three sites in each occipitalis, along the ridge at the base of the skull. Neck: two sites in each cervical paraspinal muscle, high and superficial. Shoulders: three sites in each upper trapezius. Every site is a 5-unit, 0.1 mL injection with a short, fine needle placed into the muscle (Blumenfeld 2010).

Because the map follows nerves, not pain. Migraine pain is carried by the trigeminal nerve at the front of the head and by the upper cervical nerves at the back, and the two systems meet in the brainstem. Botox works in migraine by quieting the sensory nerve endings near where it is injected, so they release fewer of the peptides that keep the pain system sensitized (Burstein 2020). The occipitalis, paraspinal and trapezius sites cover the greater and lesser occipital nerves and the cervical branches that feed the back half of that network. The PREEMPT trials that showed benefit used the full map, so a map without these sites has not been tested.

At Modal Pain Management NYC the map is fixed. The 31 sites and 155 units are given to every patient at every round, because that is the FDA label dose and the trials that produced the evidence used all 31 sites. The PREEMPT trial design also allowed follow-the-pain injections: up to 40 additional units at up to 8 extra sites in the temporalis (up to 10 units), occipitalis (up to 10 units) and trapezius (up to 20 units), and trial patients received 155 to 195 units (Dodick 2010). Those extra units are not added here.

Yes, and the anatomy work spells out why (Blumenfeld 2017). Depth: the injections go into the muscle just under the skin, and an injection too deep in the neck weakens the muscles that hold the head up. Angle: the brow sites are placed high and angled away from the eye to keep the toxin out of the eyelid muscle. Completeness: all 31 sites, every time, rather than a reduced forehead-and-temple map. Timing matters too. Headache days kept falling across five rounds in the PREEMPT program (Aurora 2011), so a course given at fewer sites, or judged after one round, is not a fair test.

At Modal Pain Management NYC the self-pay price for the 155-unit PREEMPT protocol is $2,000 per session, all-inclusive — the physician fee, the 31 injections, and the drug — repeated every 12 weeks. For commercially insured patients with chronic migraine the drug and the procedure are usually covered with prior authorization, and what you pay depends on your deductible and coinsurance. The coverage guide explains what the authorization needs, and the current prices are on our self-pay pricing page.

Ready to Get Out of Pain?

Schedule a consultation with Dr. Movshis — same-week appointments are routinely available.

5.0 90 Google Reviews Dual ABA Board-Certified Anesthesiology & Pain Medicine 369 Lexington Ave, Floor 25 Midtown Manhattan, NYC 10017